New and Generic Drug Approvals
New and Generic Drug Approvals
April 12, 2013
Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
---|---|---|---|---|
Colgate Total | sodium fluoride; triclosan | Paste; Dental | Colgate Palmolive | Manufacturing Change or Addition |
Docetaxel | docetaxel | Injectable; Injection | Actavis Inc | Approval |
Ortho Evra | ethinyl estradiol; norelgestromin | Film, Extended Release; Transdermal | Janssen Pharms | Manufacturing Change or Addition |
Oxycodone and Acetaminophen | acetaminophen; oxycodone hydrochloride | Tablet; Oral | Actavis Elizabeth | Approval |
Perjeta | pertuzumab | Vial; Single-Use | Genentech | Efficacy Supplement with Clinical Data to Support |
Rocephin | ceftriaxone sodium | Injectable; Im-Iv | Hoffmann La Roche | Labeling Revision |
Rocephin | ceftriaxone sodium | Injectable; Injection | Hoffmann La Roche | Labeling Revision |
Rocephin Kit | ceftriaxone sodium; lidocaine | Injectable; Injection | Hoffmann La Roche | Labeling Revision |
Sitavig | acyclovir | Tablet; Buccal | Bioalliance Pharma Sa | Approval |
Vascepa | icosapent ethyl | Capsule; Oral | Amarin Pharma Inc | Manufacturing Change or Addition |
Comentarios
Publicar un comentario